Physician profile
Wei Chen
NPI 1033605548
$1,513.45
in general payments reported to CMS, 2019-2025
10 companies · $1,252 in 2025
The $1,252 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $261 · 2025: $1,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $258.76 | 2025 | |
| Alnylam Pharmaceuticals INC. | $227.44 | 2025 | Amvuttra |
| Legend Biotech USA INC. | $146.95 | 2025 | Carvykti |
| Daiichi Sankyo INC. | $134.59 | 2025 | Vanflyta |
| Astellas Pharma US INC | $131.30 | 2024 | Vyloy |
| Fresenius Kabi USA, LLC | $129.70 | 2024 | Smoflipid |
| Amgen INC. | $128.33 | 2025 | Evenity |
| Vertex Pharmaceuticals Incorporated | $119.70 | 2025 | |
| Karyopharm Therapeutics INC. | $118.75 | 2025 | Xpovio |
| Glaxosmithkline, LLC. | $117.93 | 2025 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.